Global Retirement Partners’s Theravance Biopharma TBPH Stock Holding History

Global Retirement Partners’s Portfolio TBPH Stock Details TBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.36K	Buy	+315	New	+$5.21K	﹤0.01%	3677
2025 Q4	$5.61K	Hold	300	–	–	﹤0.01%	3399
2025 Q3	$4.38K	Hold	300	–	–	﹤0.01%	3029
2025 Q2	$3.31K	Buy	+300	New	+$2.92K	﹤0.01%	3056
2024 Q4	$2.82K	Hold	300	–	–	﹤0.01%	2940
2024 Q3	$2.42K	Hold	300	–	–	﹤0.01%	2878
2024 Q2	$2.54K	Hold	300	–	–	﹤0.01%	2884
2024 Q1	$2.69K	Hold	300	–	–	﹤0.01%	2633
2023 Q4	$2.89K	Hold	300	–	–	﹤0.01%	2533
2023 Q3	$2.64K	Hold	300	–	–	﹤0.01%	2427
2023 Q2	$3.1K	Hold	300	–	–	﹤0.01%	2382
2023 Q1	$3.37K	Hold	300	–	–	﹤0.01%	2305
2022 Q4	$3.37K	Buy	+300	New	+$3.15K	﹤0.01%	2160
2020 Q1	–	Sell	-57	Closed	-$1K	–	1683
2019 Q4	$1K	Hold	57	–	–	﹤0.01%	1568
2019 Q3	$1K	Hold	57	–	–	﹤0.01%	1552
2019 Q2	$1K	Buy	+57	New	+$1.16K	﹤0.01%	1547

Other funds holding TBPH

MAP

Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return

ICM

Irenic Capital Management New York $2.08B AUM 19.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Global Retirement Partners's TBPH Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Theravance Biopharma (TBPH) in Q2 2026: 315 shares worth $5.36K. The stake represents ﹤0.01% of the portfolio and ranks #3677 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in TBPH as recently as Q4 2025.

Global Retirement Partners first reported a position in TBPH in Q2 2019 and has held it in 16 quarters since. The position peaked at $5.61K in Q4 2025. 180 funds tracked by Wall St. Rank hold TBPH as of Q2 2026.

Global Retirement Partners held 315 shares of Theravance Biopharma worth $5.36K as of Q2 2026.
Theravance Biopharma was a new Global Retirement Partners position in Q2 2026.
Theravance Biopharma made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #3677 holding.
Global Retirement Partners first reported a position in Theravance Biopharma in Q2 2019 and has held it in 16 quarters since.
Global Retirement Partners's Theravance Biopharma position peaked at $5.61K in Q4 2025.
180 funds tracked by Wall St. Rank held Theravance Biopharma as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.